Fulgent Genetics’s Investor Alert: Kaplan Fox Reminds Investors of an Important Deadline
09 nov. 2022 11h35 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a securities class action case has been brought against Fulgent Genetics, Inc....
FULGENT GENETICS’ INVESTOR ALERT: Kaplan Fox Investigates Potential Securities Fraud
23 sept. 2022 15h29 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Fulgent Genetics, Inc. (“Fulgent” or the "Company”)...